Navigation Links
A better way to help high-risk pregnant smokers
Date:6/21/2012

Cigarette smoking among drug dependent pregnant women is alarmingly high, estimated at 77 to 99%. Programs that treat pregnant patients for substance use disorders often fail to address cigarette smoking despite the clear risks to both mother and child, including ectopic pregnancy, spontaneous abortion, preterm delivery, low birth weight, and Sudden Infant Death Syndrome. However, programs to help people quit smoking do not seem to interfere with drug abuse treatment, and may actually improve drug abstinence rates.

One of the most effective methods of helping people to quit smoking is contingency management, which gives smokers monetary incentives for meeting target goals. Researchers at Johns Hopkins University's Center for Addiction and Pregnancy recently used contingency management to shape smoking reduction and abstinence in drug-dependent pregnant women, with promising results.

One hundred and three pregnant smokers who were prescribed methadone maintenance for heroin dependence were enrolled in a study comparing three conditions. A third of the women were enrolled in a contingency management shaping program and received escalating monetary incentives for reducing their level of cigarette smoking or by being abstinent as measured by breath carbon monoxide levels. The smoking reduction targets required for monetary incentives increased over time from minimal reduction in the early phases of treatment to the requirement of total abstinence by week 12. A relapse meant no monetary incentive was earned and the participant returned to the lowest level of payment. A third of the women could earn incentives for reduced smoking according to a schedule of payments not connected to the woman's own smoking behaviour (non-contingent incentives). The final group of women received information about the risks of smoking during pregnancy but received no money for reduced smoking.

All of the groups showed some reduction in smoking levels during the experiment, but the women in the contingency management group greatly outperformed the two other groups. Nearly half of the contingency management women met the target of 75% reduction at least once, and a third of them met criteria for smoking abstinence (100% reduction) at least once by week 12. In contrast, none of the other condition participants met the abstinence criteria and only 2% of participants met the 75% reduction target during the study period.

The benefits of contingency management carried on after the experiment. The women in the contingent group had fewer pre-term births (17%, compared with 25% and 29% in the other two groups) and fewer babies with low birth weight (20%, compared with 38% and 43%), and they reported less smoking in the weeks after birth.

The results of the study indicate that contingency management programs are an effective way to reduce smoking in the hard-to-treat population of drug-dependent pregnant women.


'/>"/>
Contact: Stephanie Desmon
sdesmon1@jhmi.edu
44-141-095-58665
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. 'Music Makes It Better' Campaign Launches with Justin Bieber, Victoria Justice, and The Band Perry
2. Elderly prisoners need better medical care, according to report
3. Exercise Controls Weight in White Girls Better Than in Black Girls: Study
4. ASCO: Younger colon cancer patients have worse prognosis at diagnosis, yet better survival
5. Half of Americans with individual health plans could gain better coverage under the ACA
6. Phone contact with nurses linked with better outcomes for women with gestational diabetes
7. Better tests for sleeping sickness
8. UC students design a better pill bottle for the blind and visually impaired
9. Women fare better than men, but need more blood after kidney cancer surgery
10. New type of retinal prosthesis could better restore sight to blind, Stanford study says
11. Sooner Is Better for Controlling Obese Kids Weight: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: